Peter Nicklin

Peter Nicklin serves as Chairman of the Board at Hansa Biopharma and Healthcare at Home since July 2022 and September 2018, respectively, while also holding the same position at Tunstall Healthcare (UK) until July 2024 and at Versantis AG until September 2022. Previously, Peter Nicklin was CEO and Member of the Board at Amann Girrbach and worked as a Consultant and Advisor to Pharmaceutical and Med Tech companies from April 2014 to July 2017. Notably, Peter Nicklin served as CVP and President of Baxter International Inc. for the Europe, Middle East and Africa region from 2006 to 2014, and held various leadership roles at Bayer HealthCare, Novartis, and Bristol-Myers Squibb. Peter Nicklin is a Chartered Accountant and holds a Bachelor's Degree in Finance and Law from Lancaster University, as well as an International Baccalaureate from UWC South East Asia.